KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Community Health Systems (CYH) Gains from Sales and Divestitures (2016 - 2025)

Community Health Systems (CYH) has disclosed Gains from Sales and Divestitures for 15 consecutive years, with $5894.0 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Gains from Sales and Divestitures changed 0.0% year-over-year to $5894.0, compared with a TTM value of $5894.0 through Jun 2025, changed 0.0%, and an annual FY2024 reading of $135278.0, changed N/A over the prior year.
  • Gains from Sales and Divestitures was $5894.0 for Q2 2025 at Community Health Systems, down from $1.6 million in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $2.3 million in Q4 2021 and bottomed at $4001.0 in Q3 2023.
  • Average Gains from Sales and Divestitures over 5 years is $591946.7, with a median of $95577.0 recorded in 2023.
  • The sharpest move saw Gains from Sales and Divestitures crashed 93.47% in 2022, then surged 2109.28% in 2024.
  • Year by year, Gains from Sales and Divestitures stood at $2.3 million in 2021, then plummeted by 93.47% to $151058.0 in 2022, then plummeted by 97.35% to $4001.0 in 2023, then skyrocketed by 3281.1% to $135278.0 in 2024, then crashed by 95.64% to $5894.0 in 2025.
  • Business Quant data shows Gains from Sales and Divestitures for CYH at $5894.0 in Q2 2025, $1.6 million in Q1 2025, and $135278.0 in Q4 2024.